pisco_log
banner

Enterprise Performance, R & D Expense Ratio and the Total Factor Productivity of TCM Listed Enterprises -- Empirical Research in the Context of New Quality Productivity

Zhiran Hu, Lijing Luo, Hui Li, Linqian Dong

Abstract


This study, focusing on the high-quality development of traditional Chinese medicine (TCM) enterprises, examines A-share listed
TCM companies from 2018 to 2022. It uncovers that operational performance positively influences total factor productivity, with R&D expenses exerting a negative intermediary effect. This impact is more pronounced in smaller firms. Enhancing operational performance is thereby crucial for the successful transformation and high-quality growth of TCM enterprises.

Keywords


TCM; Enterprise performance; R & D expense ratio; TFP

Full Text:

PDF

Included Database


References


[1] Ye Bin. An empirical study on the equity structure and total factor productivity of listed companies with enterprise group background in

China [J]. Statistics and Decision-making, 2010, (05): 148-151.

[2] Zhang Xiaodi, Yao Yao. Study on the influence of human capital of private entrepreneurs on regional innovation and total factor productivity in China Empirical analysis based on panel data of nine provinces and cities in eastern China [J]. Journal of Zhejiang University (Humanities and Social Sciences edition), 2011, 41 (05): 94-106.

[3] Fan Jianshuang. Research on measuring the performance of large contracting enterprises in China's construction industry [J]. Journal of

Civil Engineering, 2011, 44 (10): 124-131.

[4] Li Daohe, Chi Zexin. Research on the Performance Relationship between policy support and leading agricultural enterprises Take

Jiangxi Province as an example [J]. Agricultural technology and economy, 2011, (12): 4-10.

[5] Yu Yingze, Zhang Yan. Decomposition of regional efficiency difference and total factor productivity growth rate of high-tech industries

in China Based on the production function analysis of three-input random frontier [J]. Research on Industrial Economy, 2012, (01):

44-53.

[6] Cheng Huifang, Lu Jiajun. Empirical analysis of the effect of knowledge capital on the total factor productivity of industrial enterprises [J].

Economic Research, 2014, 49 (05): 174-187.

[7] Ji Kevin. Research on the growth effect and influencing factors of total factor productivity of biological agriculture in China Empirical investigation of 32 listed companies [J]. Soft Science, 2015, 29 (02): 41-45.

[8] Wang Ping, Cao Liang, Zhu Wenjuan, et al. Import tariff reduction and total factor productivity of enterprises Empirical research

based on micro data of Chinese enterprises [J]. Macroeconomic Research, 2015, (08): 48-64 + 116.

[9] Cold army. Research on the correlation between technology innovation and performance of gem listed companies Empirical research based on total factor productivity [J]. Technology and Economy, 2015, 28 (05): 31-35 + 90...

[10] Qiu Yunjie, Wei Wei. The influence of R & D investment on enterprise performance research based on propensity score matching

method [J]. Contemporary Finance, 2016, (03): 96-106.

[11] Luo Nengsheng, Zeng Keqiang. Social capital, regional differences and total factor productivity Empirical study based on DEA

method [J]. Journal of Henan Normal University (Philosophy and Social Sciences edition), 2018, 45 (01): 29-37.

[12] Yang Xue, He Yucheng, and Liu Cheng. The impact of government subsidies on total factor productivity of listed agricultural companies

Analysis based on panel threshold model [J]. Journal of Hunan Agricultural University (Social Science Edition), 2020, 21 (03): 59-66.

[13] Liu Mingkang. Status, problems and countermeasures [R]. Hong Kong: The Institute of Global Economics and Finance, The Chinese University of Hong Kong, 2016:2-3.

[14] Wang Huaiming, Zhou Xinyu. Impact of ESG performance on corporate debt financing costs [J]. Business Accounting, 2023, (09): 10-16.

[15] Li Duan, Guo Jiaxuan, Li Haiying. ESG performance, technological innovation and total factor productivity Evidence from China's pharmaceutical industry [J]. Accounting Monthly, 2023, 44 (11): 143-150.


Refbacks

  • There are currently no refbacks.